Skip to main content
Clinical Trials/CTRI/2025/10/096034
CTRI/2025/10/096034Not yet recruitingPhase 3

Effectiveness of Ostikot Forte Tablet in Osteoarthritis of Knee joint -A Quasi- Experimental Study

The managing trustee1 site in 1 country32 target enrollmentStarted: December 11, 2025Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
32
Locations
1
Primary Endpoint
Pain Reduction: Measured using the Visual Analog Scale (VAS) for pain at baseline & after 2 weeks, 1 month and 3months

Study Overview

Brief Summary

This quasi-experimental study evaluates the effectiveness of Ostikot Forte Tablet in knee osteoarthritis. Thirty-two patients (aged 51–80 years) will receive 2 tablets twice daily for 90 days. Outcomes include pain reduction (VAS), joint function (WOMAC), and bone health (calcium, vitamin D, BMD). The study aims to provide evidence on its role in improving pain, mobility, and bone strength.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
51.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Participants with knee joint pain satisfying the diagnostic criteria.

Exclusion Criteria

  • 1.History of rheumatoid arthritis or other inflammatory joint diseases 2.Known case of Malignancy
  • Known Cardiovascular disorders (such as Coronary artery disease, Rheumatic heart disease, congenital heart disease and Cardiac myopathy)
  • Known Hepatic disorders and Endocrinal disorders
  • Pregnant and lactating females
  • Any other condition that may jeopardize the study.

Outcomes

Primary Outcomes

Pain Reduction: Measured using the Visual Analog Scale (VAS) for pain at baseline & after 2 weeks, 1 month and 3months

Time Frame: 90days

Secondary Outcomes

  • Joint Function & Mobility: Assessed using the WOMAC Index 9(Western Ontario & McMaster Universities Osteoarthritis Index)- at baseline & after 2 weeks, 1 month & after 3 months(Blood test – Calcium blood test, blood vitamin D TEST - at baseline & after 1 month)

Investigators

Sponsor
The managing trustee
Sponsor Class
Other [Charitable institution]
Responsible Party
Principal Investigator
Principal Investigator

Dr Anoop AK

Vaidyaratnam P S Variers Aryavaidyasala Kottakkal

Study Sites (1)

Loading locations...

Similar Trials

Study on the Effect of Ostikot Forte... | Clinical Trial